SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024685
Filing Date
2022-11-14
Accepted
2022-11-14 07:25:54
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-20220930.htm   iXBRL 10-Q 2521533
2 EX-31.1 cogt-ex31_1.htm EX-31.1 17372
3 EX-31.2 cogt-ex31_2.htm EX-31.2 17360
4 EX-32.1 cogt-ex32_1.htm EX-32.1 11695
5 EX-32.2 cogt-ex32_2.htm EX-32.2 11670
6 GRAPHIC img156523800_0.jpg GRAPHIC 47652
7 GRAPHIC img156523800_1.jpg GRAPHIC 71271
  Complete submission text file 0000950170-22-024685.txt   7911244

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cogt-20220930_pre.xml EX-101.PRE 291618
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cogt-20220930.xsd EX-101.SCH 47890
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cogt-20220930_lab.xml EX-101.LAB 392139
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cogt-20220930_def.xml EX-101.DEF 196537
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cogt-20220930_cal.xml EX-101.CAL 46804
53 EXTRACTED XBRL INSTANCE DOCUMENT cogt-20220930_htm.xml XML 1178181
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 221380222
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences